Home | About the eMC | Help | Mobile
eMC - trusted, up to date and comprehensive information about medicines
Link to eMC medicine guides website
eMC homepage
Advanced search
Get Medicines Compendium UK app here

Bayer plc
Bayer House, Strawberry Hill, Newbury, Berkshire, RG14 1JA
Telephone: +44 (0)1635 563 000
Fax: +44 (0)1635 563 393
WWW: http://www.bayer.co.uk

Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Patient Information Leaflet last updated on the eMC: 22/05/2012
PIL Levitra 10mg film-coated tablets

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 22/05/2012 and displayed until Current
Reasons for adding or updating:
  • Improved Electronic Presentation
Updated on 18/05/2012 and displayed until 22/05/2012
Reasons for adding or updating:
  • Improved Electronic Presentation
  • PIL Submitted in error
Updated on 08/03/2012 and displayed until 18/05/2012
Reasons for adding or updating:
  • Change to date of revision
Updated on 23/08/2011 and displayed until 08/03/2012
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
Updated on 10/06/2011 and displayed until 23/08/2011
Reasons for adding or updating:
  • Change to how the medicine works
  • Change to Further Information section
  • Change to date of revision
  • Change of contra-indications
Updated on 28/07/2009 and displayed until 10/06/2011
Reasons for adding or updating:
  • Change to date of revision
  • Change to Marketing Authorisation Holder
  • Change to name of manufacturer
Updated on 11/08/2008 and displayed until 28/07/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to drug interactions
Updated on 24/04/2008 and displayed until 11/08/2008
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
Updated on 24/01/2008 and displayed until 24/04/2008
Reasons for adding or updating:
  • Change to side-effects
Updated on 05/07/2006 and displayed until 24/01/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change of contra-indications
  • Change to date of revision
Updated on 25/11/2005 and displayed until 05/07/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to date of revision
  • Change to side-effects
Updated on 10/11/2005 and displayed until 25/11/2005
Reasons for adding or updating:
  • Change of manufacturer
  • Change to date of revision
Updated on 03/06/2005 and displayed until 10/11/2005
Reasons for adding or updating:
  • Change to side-effects
  • Change to date of revision
Updated on 28/06/2004 and displayed until 03/06/2005
Reasons for adding or updating:
  • Change to side-effects
Updated on 12/09/2003 and displayed until 28/06/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 11/03/2003 and displayed until 12/09/2003
Reasons for adding or updating:
  • New PIL for new product

Active Ingredients/Generics

 
  vardenafil hydrochloride